HARROW, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.22 USD | +34.38% |
|
+47.90% | +44.46% |
| 02:00pm | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 13/05 | Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 43Cr | - | - | - | |||
| 68TCr | ||||||
| 59TCr | ||||||
| 36TCr | ||||||
| 33TCr | ||||||
| 28TCr |
- Stock Market
- Equities
- HROW Stock
- Charts Harrow, Inc.
- Sector Chart
